Neurodevelopmental outcomes of preterm infants in Bangladesh

Naila Z Khan1, Humaira Muslima, Monowara Parveen

  • 1Child Development Centre, Child Development and Neurology Unit, Dhaka Shishu (Children's) Hospital, Sher-e-Bangla Nagar, Dhaka 1207, Bangladesh. zakhan@bangla.net

Pediatrics
|July 5, 2006
PubMed

Insights

Preterm infants in Bangladesh face high neurodevelopmental risks. Early identification by a multidisciplinary team is crucial for better outcomes in low-resource settings.

Area of Science:

  • Neonatal care
  • Developmental pediatrics
  • Global health

Background:

  • Preterm infants are vulnerable to neurodevelopmental impairments.
  • Low-resource settings present unique challenges in monitoring infant development.
  • Tertiary hospitals play a key role in managing high-risk neonates.

Purpose of the Study:

  • To assess neurodevelopmental outcomes in preterm infants in Bangladesh.
  • To evaluate the effectiveness of a multidisciplinary team approach.
  • To identify risk factors influencing infant mortality and impairment.

Main Methods:

  • Infants born before 33 weeks gestational age were enrolled.
  • Serial neurodevelopmental assessments were conducted by physicians and psychologists.
  • Risk stratification and severity grading of impairments were performed.

Main Results:

  • 65% of enrolled infants survived, with lower family income linked to mortality.
  • Among those followed for at least 12 months, 78% had neurodevelopmental impairments (45% mild, 23% serious).
  • Cognitive impairment was the most frequent deficit (60%); multidisciplinary assessment identified more mild impairments.

Conclusions:

  • Parental education and family income significantly impacted postdischarge mortality.
  • Two-thirds of preterm infants exhibited neurodevelopmental impairments.
  • A multidisciplinary team approach is essential for early and accurate identification of impairments in low-resource settings.
Abstract

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Neurulation01:30

Neurulation

Neurulation is the embryological process which forms the precursors of the central nervous system and occurs after gastrulation has established the three primary cell layers of the embryo: ectoderm, mesoderm, and endoderm. In humans, the majority of this system is formed via primary neurulation, in which the central portion of the ectoderm—originally appearing as a flat sheet of cells—folds upwards and inwards, sealing off to form a hollow neural tube. As development proceeds, the anterior...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...